Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 3135737Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
NIH Funding · FY2025
Linked Award Amount
$2M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#6,972
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Liang Qiao as a PI. Multi-PI records show the full award amount for context.
- 1R01AI170894-01A1R01A Novel T cell-based Vaccine to Prevent Dengue/Zika virus infection$781.7Kaward amount
- 1R01AI188950-01R01Rational design of a unique vaccine for emerging pandemic coronaviruses$755.2Kaward amount
- $423.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Liang Qiao as a PI.
FY2025 award administered by Loyola University Chicago (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardLoyola University Chicago
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #6972
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #4898
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Liang Qiao.